Arrowhead Pharmaceuticals announced that the first patient has been treated in Takeda Pharmaceuticals’ phase 3 clinical trial of fazirsiran for the treatment of alpha-1 antitrypsin deficiency associated liver disease.Fazirsiran, an investigational RNA interference therapy intended to reduce the production of the mutant alpha-1 antitrypsin protein, was co-developed by both Takeda and Arrowhead. The drug was…
Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection was noninferior to open distal gastrectomy in patients with locally advanced gastric cancer, according to 5-year follow-up data published in JAMA Surgery.“For advanced gastric cancer (AGC), laparoscopic gastrectomy is considered technically difficult owing to the large tumor size and lymph node metastasis. To clarify the safety and…
The Florida Gastroenterologic Society was originally conceived in 1965 by James L. Borland, M.D., a well respected Gastroenterologist who practiced in Jacksonville, Florida.